INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2010
Total net assets |
£103.1m |
NAV per share |
173.2p |
Share price |
146.3p |
Total value of unquoted investments |
£23.1m |
Total number of portfolio companies |
60 |
Cash |
0% NAV |
Cash committed and reserved to unquoted investments |
9% NAV |
Portfolio companies with < 1 year of cash |
9% NAV |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
5.54 |
Amgen |
5.29 |
Micromet |
5.26 |
Shire Ltd |
5.11 |
Gilead Sciences |
4.60 |
Insulet |
3.71 |
Alexion Pharmaceuticals |
3.56 |
Teva |
3.43 |
Genzyme |
3.13 |
Cadent |
3.12 |
|
----------- |
Total |
42.75 |
Geographical Allocation |
% |
United States |
74 |
Europe |
24 |
Australia |
2 |
Cash |
0 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
78 |
Unquoted |
22 |
Cash |
0 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 JANUARY 2011